TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effects of Losartan and Spironolactone on Residual Renal Function Preservation in Peritoneal Dialysis Patients
Brief Summary: Aldosterone blockade is useful in preserving residual renal function in patients on PD.The long term efficacy of dual blockade of the RAAS is better than monotherapy.


Options:
A: Arm Label: Spironolactone 12.5 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Spironolactone | Arm Label: Spironolactone 25 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Spironolactone | Arm Label: Spironolactone 50 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Spironolactone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Spironolactone | Intervention Type: DRUG; Name: Spironolactone; Assigned to Arm(s): Placebo, Spironolactone 12.5 mg, Spironolactone 25 mg, Spironolactone 50 mg
B: Arm Label: Losartan; Type: EXPERIMENTAL; Interventions: Drug: Losartan | Arm Label: spirolactone; Type: EXPERIMENTAL; Interventions: Drug: spirolactone | Arm Label: losartan in combination with spirolactone; Type: EXPERIMENTAL; Interventions: Drug: Losartan, Drug: spirolactone | Arm Label: blank control; Type: SHAM_COMPARATOR; Interventions: Other: blank control | Intervention Type: DRUG; Name: Losartan; Assigned to Arm(s): Losartan, losartan in combination with spirolactone | Intervention Type: DRUG; Name: spirolactone; Assigned to Arm(s): losartan in combination with spirolactone, spirolactone | Intervention Type: OTHER; Name: blank control; Assigned to Arm(s): blank control
C: Arm Label: Spironolactone + Placebo; Type: EXPERIMENTAL; Interventions: Drug: Spironolactone, Drug: Placebo | Arm Label: Double Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Spironolactone + L-arginine; Type: EXPERIMENTAL; Interventions: Drug: Spironolactone, Dietary Supplement: L-arginine | Arm Label: L-arginine + Placebo; Type: EXPERIMENTAL; Interventions: Dietary Supplement: L-arginine, Drug: Placebo | Intervention Type: DRUG; Name: Spironolactone; Assigned to Arm(s): Spironolactone + L-arginine, Spironolactone + Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: L-arginine; Assigned to Arm(s): L-arginine + Placebo, Spironolactone + L-arginine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Double Placebo, L-arginine + Placebo, Spironolactone + Placebo
D: Arm Label: spironolactone; Type: EXPERIMENTAL; Interventions: Drug: Spironolactone | Intervention Type: DRUG; Name: Spironolactone; Assigned to Arm(s): spironolactone

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Placebo-Controlled Study of an Herbal Tea to Support Lactation
Brief Summary: The overall aims of this project are to 1) determine the quality of life effects of a combination herbal galactagogue tea in lactating women, and 2) measure changes in maternal blood concentration of oxytocin, prolactin, and milk production. The defined outcome measures will include quality of life measures in the breastfeeding woman and basic infant health. If the tea proves safe and effective, then it can provide a proven all-natural and organic supplement for increasing lactation in women. This in turn will increase quality of life for both the infant and the mother.


Options:
A: Arm Label: study herbal tea; Type: EXPERIMENTAL; Interventions: Dietary Supplement: study herbal tea | Arm Label: herbal placebo tea; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: herbal placebo tea | Intervention Type: DIETARY_SUPPLEMENT; Name: study herbal tea; Assigned to Arm(s): study herbal tea | Intervention Type: DIETARY_SUPPLEMENT; Name: herbal placebo tea; Assigned to Arm(s): herbal placebo tea
B: Arm Label: Standard care plus metformin; Type: EXPERIMENTAL; Interventions: Behavioral: Standard care, Drug: Metformin | Arm Label: Standard Care plus placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Standard care, Drug: Placebo | Intervention Type: BEHAVIORAL; Name: Standard care; Assigned to Arm(s): Standard Care plus placebo, Standard care plus metformin | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Standard care plus metformin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Standard Care plus placebo
C: Intervention Type: DRUG; Name: domperidone; Assigned to Arm(s): N/A
D: Arm Label: a; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metoclopramide (Maxolon) | Arm Label: b; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: c; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metoclopramide (Maxolon) | Arm Label: d; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Metoclopramide (Maxolon); Assigned to Arm(s): a, c | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): b, d

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mindfulness Interventions and Chronic Symptoms
Brief Summary: The primary objective of this study to determine the feasibility and acceptability of a mindfulness intervention for adolescents with juvenile fibromyalgia/ chronic widespread pain and other similar chronic symptoms.


Options:
A: Arm Label: Multimodal Rehabilitation Program; Type: EXPERIMENTAL; Interventions: Behavioral: Multimodal Rehabilitation Program | Arm Label: Care as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Care as Usual | Intervention Type: BEHAVIORAL; Name: Multimodal Rehabilitation Program; Assigned to Arm(s): Multimodal Rehabilitation Program | Intervention Type: BEHAVIORAL; Name: Care as Usual; Assigned to Arm(s): Care as Usual
B: Arm Label: Chiropractic + Exercise; Type: EXPERIMENTAL; Interventions: Other: Chiropractic + Exercise | Arm Label: Exercise; Type: ACTIVE_COMPARATOR; Interventions: Other: Exercise | Intervention Type: OTHER; Name: Chiropractic + Exercise; Assigned to Arm(s): Chiropractic + Exercise | Intervention Type: OTHER; Name: Exercise; Assigned to Arm(s): Exercise
C: Arm Label: Behavioural Intervention/Feedback; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interview | Arm Label: Video Attention Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Video Attention Control | Intervention Type: BEHAVIORAL; Name: Motivational Interview; Assigned to Arm(s): Behavioural Intervention/Feedback | Intervention Type: OTHER; Name: Video Attention Control; Assigned to Arm(s): Video Attention Control
D: Arm Label: Mindfulness Group; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness Group | Intervention Type: BEHAVIORAL; Name: Mindfulness Group; Assigned to Arm(s): Mindfulness Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of a "Fast Track" Respiratory Therapy Clinic for Patients With Suspected Severe Sleep-Disordered Breathing
Brief Summary: Access to medical care for patients with breathing disorders during sleep is a major problem for Canadians. Recently, there has been increasing interest in how health care providers who are not physicians can help to improve access to medical care for these patients, but it is unclear whether patients with severe sleep-disordered breathing who receive care from these non-physician providers have the same response to treatment as patients who receive care from physicians. Since these severe have a high risk of developing cardiac and respiratory complications and of being hospitalized, an initiative to improve access such as the use of non-physician providers could be of great benefit to individual patients and the health care system.

The objectives of this project are:

1. to determine whether patients with severe breathing disorders during sleep have the same response to treatment when cared for by non-physician health care providers (respiratory therapists) as they do when cared for by physicians;
2. to determine the effects of non-physician health care provider treatment to patient access;
3. to determine health care utilization and related costs associated with non-physician health care provider treatment.


Options:
A: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Device: CPAP | Intervention Type: DEVICE; Name: CPAP; Assigned to Arm(s): 2
B: Arm Label: Standard Management; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Fast Track; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Fast Track | Intervention Type: PROCEDURE; Name: Fast Track; Assigned to Arm(s): Fast Track
C: Arm Label: OSA Health Education & Support Group; Type: EXPERIMENTAL; Interventions: Behavioral: Peer Based Sleep Health Education and Social Support | Arm Label: Attention Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Attention Control Group | Intervention Type: BEHAVIORAL; Name: Peer Based Sleep Health Education and Social Support; Assigned to Arm(s): OSA Health Education & Support Group | Intervention Type: BEHAVIORAL; Name: Attention Control Group; Assigned to Arm(s): Attention Control Group
D: Arm Label: Standard Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard care | Arm Label: Intensive care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Intensive care | Intervention Type: BEHAVIORAL; Name: Standard care; Assigned to Arm(s): Standard Care | Intervention Type: BEHAVIORAL; Name: Intensive care; Assigned to Arm(s): Intensive care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Technology to Enhance Treatment for Early Conduct Problems in Low Income Families
Brief Summary: This study aims to the test the efficacy and cost effectiveness of new service delivery methods to enhance the reach and impact of the standard of care treatment, Behavioral Parent Training (BPT), for early onset disruptive behavior disorders.


Options:
A: Arm Label: Behavioral Parent Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Behavioral Parent Training | Arm Label: Behavioral Parent Training - Enhanced; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Parent Training | Intervention Type: BEHAVIORAL; Name: Behavioral Parent Training; Assigned to Arm(s): Behavioral Parent Training, Behavioral Parent Training - Enhanced
B: Arm Label: Usual Care control (Parenting tips); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Strongest Families; Type: EXPERIMENTAL; Interventions: Behavioral: Strongest Families | Intervention Type: BEHAVIORAL; Name: Strongest Families; Assigned to Arm(s): Strongest Families
C: Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Home visitation through pregnancy; Type: EXPERIMENTAL; Interventions: Behavioral: nurse home visitation | Arm Label: Home visitation through age 2; Type: EXPERIMENTAL; Interventions: Behavioral: nurse home visitation | Intervention Type: BEHAVIORAL; Name: nurse home visitation; Assigned to Arm(s): Home visitation through age 2, Home visitation through pregnancy
D: Arm Label: Helping the Noncompliant Child (HNC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Helping the Noncompliant Child (HNC) | Arm Label: Technology-Enhanced HNC (TE-HNC); Type: EXPERIMENTAL; Interventions: Behavioral: Technology-Enhanced Helping the Noncompliant Child (TE-HNC) | Intervention Type: BEHAVIORAL; Name: Helping the Noncompliant Child (HNC); Assigned to Arm(s): Helping the Noncompliant Child (HNC) | Intervention Type: BEHAVIORAL; Name: Technology-Enhanced Helping the Noncompliant Child (TE-HNC); Assigned to Arm(s): Technology-Enhanced HNC (TE-HNC)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Intervention to Feedback 'Early' Non-Adherence Data to ImproveCardiovascular Disease Risk Factor Outcomes in Patients With Diabetes
Brief Summary: This multisite pragmatic clinical trial was designed to assess the effectiveness of a single scripted telephone call to diabetes patients who (a) were currently above recommended clinical goals for glucose, blood pressure, or lipids, and (b) had recently been prescribed a new medication for that specific clinical domain. The goals of the intervention were to improve primary adherence and persistence to the newly prescribed medication and to improve control of glucose, blood pressure, and lipids.


Options:
A: Arm Label: A, 1, I; Type: EXPERIMENTAL; Interventions: Device: Home blood pressure tele-management system. | Arm Label: A, 2, I; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care. | Intervention Type: DEVICE; Name: Home blood pressure tele-management system.; Assigned to Arm(s): A, 1, I | Intervention Type: OTHER; Name: Usual care.; Assigned to Arm(s): A, 2, I
B: Arm Label: Intervention phone call; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention Phone Call | Arm Label: Control arm - usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intervention Phone Call; Assigned to Arm(s): Intervention phone call
C: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Electronic Pill Bottle tracking | Arm Label: Feedback group; Type: EXPERIMENTAL; Interventions: Behavioral: Electronic Pill Bottle tracking, Behavioral: Adherence Messaging | Arm Label: Adherence partner group; Type: EXPERIMENTAL; Interventions: Behavioral: Electronic Pill Bottle tracking, Behavioral: Social Influence | Arm Label: Adherence partner along with feedback; Type: EXPERIMENTAL; Interventions: Behavioral: Electronic Pill Bottle tracking, Behavioral: Adherence Messaging, Behavioral: Social Influence | Intervention Type: BEHAVIORAL; Name: Electronic Pill Bottle tracking; Assigned to Arm(s): Adherence partner along with feedback, Adherence partner group, Control, Feedback group | Intervention Type: BEHAVIORAL; Name: Adherence Messaging; Assigned to Arm(s): Adherence partner along with feedback, Feedback group | Intervention Type: BEHAVIORAL; Name: Social Influence; Assigned to Arm(s): Adherence partner along with feedback, Adherence partner group
D: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Comprehensive Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Comprehensive Intervention | Intervention Type: BEHAVIORAL; Name: Comprehensive Intervention; Assigned to Arm(s): Comprehensive Intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: An Intervention to Feedback 'Early' Non-Adherence Data to ImproveCardiovascular Disease Risk Factor Outcomes in Patients With Diabetes
Brief Summary: This multisite pragmatic clinical trial was designed to assess the effectiveness of a single scripted telephone call to diabetes patients who (a) were currently above recommended clinical goals for glucose, blood pressure, or lipids, and (b) had recently been prescribed a new medication for that specific clinical domain. The goals of the intervention were to improve primary adherence and persistence to the newly prescribed medication and to improve control of glucose, blood pressure, and lipids.


Options:
A: Arm Label: Intervention phone call; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention Phone Call | Arm Label: Control arm - usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intervention Phone Call; Assigned to Arm(s): Intervention phone call
B: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Device: "COMBINED STRATEGY" | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: "COMBINED STRATEGY"; Assigned to Arm(s): Intervention group
C: Arm Label: Arm 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Arm 2; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse Behavioral intervention with Home BP Telemonitoring | Arm Label: Arm 3; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse Medication Management with Home BP Telemonitoring | Arm Label: Arm 4; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse Combined intervention with Home BP Telemonitoring | Intervention Type: BEHAVIORAL; Name: Nurse Behavioral intervention with Home BP Telemonitoring; Assigned to Arm(s): Arm 2 | Intervention Type: BEHAVIORAL; Name: Nurse Medication Management with Home BP Telemonitoring; Assigned to Arm(s): Arm 3 | Intervention Type: BEHAVIORAL; Name: Nurse Combined intervention with Home BP Telemonitoring; Assigned to Arm(s): Arm 4
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Cell Phone Intervention | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Cell Phone Intervention; Assigned to Arm(s): 1

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Insulin Degludec on Risk of Symptomatic Nocturnal Hypoglycaemia in Subjects With Type 1 Diabetes and High Risk of Nocturnal Severe Hypoglycaemia
Brief Summary: The purpose of this study is to determine whether insulin degludec compared to insulin glargine can reduce the risk of symptomatic nocturnal hypoglycaemia in subjects with the greatest potential benefit from optimised insulin treatment, which are patients with type 1 diabetes and high risk of nocturnal severe hypoglycaemia.


Options:
A: Arm Label: Insulin glargine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Insulin aspart/glargine | Arm Label: Insulin degludec; Type: EXPERIMENTAL; Interventions: Drug: Insulin aspart/degludec | Intervention Type: DRUG; Name: Insulin aspart/glargine; Assigned to Arm(s): Insulin glargine | Intervention Type: DRUG; Name: Insulin aspart/degludec; Assigned to Arm(s): Insulin degludec
B: Arm Label: insulin detemir; Type: EXPERIMENTAL; Interventions: Drug: insulin detemir, Drug: insulin aspart | Arm Label: NPH insulin; Type: EXPERIMENTAL; Interventions: Drug: insulin NPH, Drug: insulin aspart | Intervention Type: DRUG; Name: insulin detemir; Assigned to Arm(s): insulin detemir | Intervention Type: DRUG; Name: insulin NPH; Assigned to Arm(s): NPH insulin | Intervention Type: DRUG; Name: insulin aspart; Assigned to Arm(s): NPH insulin, insulin detemir
C: Arm Label: IDegAsp OD; Type: EXPERIMENTAL; Interventions: Drug: insulin degludec/insulin aspart, Drug: insulin aspart | Arm Label: IDet; Type: ACTIVE_COMPARATOR; Interventions: Drug: insulin detemir, Drug: insulin aspart | Intervention Type: DRUG; Name: insulin degludec/insulin aspart; Assigned to Arm(s): IDegAsp OD | Intervention Type: DRUG; Name: insulin detemir; Assigned to Arm(s): IDet | Intervention Type: DRUG; Name: insulin aspart; Assigned to Arm(s): IDegAsp OD | Intervention Type: DRUG; Name: insulin aspart; Assigned to Arm(s): IDet
D: Arm Label: IDeg OD; Type: EXPERIMENTAL; Interventions: Drug: insulin degludec, Drug: insulin aspart | Arm Label: IGlar OD; Type: ACTIVE_COMPARATOR; Interventions: Drug: insulin glargine, Drug: insulin aspart | Intervention Type: DRUG; Name: insulin degludec; Assigned to Arm(s): IDeg OD | Intervention Type: DRUG; Name: insulin glargine; Assigned to Arm(s): IGlar OD | Intervention Type: DRUG; Name: insulin aspart; Assigned to Arm(s): IDeg OD, IGlar OD

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Reduction of Preoperative Anxiety in Children: Electronic Tab vs Midazolam
Brief Summary: Rationale:

The most frequently used means to prevent pre-anaesthetic anxiety in children is a drug premedication. Midazolam, a benzodiazepine, is mainly used. It requires time for action, so coordination between departments and operating room, exposed to the risks of side effects and failure and this variability action. Alternative means were evaluated, such as the presence of parents during anaesthetic mask induction, distraction by clowns, hypnosis or video games.

Electronic tabs are small devices; light, easy to use with age-specific and interactive programs. Our hypothesis is that these electronic tabs are more effective in reducing anxiety and distract children compare to preoperative medication.

Methods: This is a monocentric, randomized, open-label study comparing patients aged 4 to 10 years old programmed for a short term and low level of pain outpatient surgery. My pass score will be measured when arriving at the hospital, at the time of the separation with the parents, at the time of the anaesthetic mask induction and after the surgery.

118 patients will be randomized as follows :

* Arm 1 : Hypnovel® (midazolam)
* Arm 2 : Electronic tab The recruitment is performed by general practitioners in the Lyon area.


Options:
A: Arm Label: Hypnovel® (midazolam); Type: ACTIVE_COMPARATOR; Interventions: Drug: Midazolam oral intake | Arm Label: Electronic tab; Type: EXPERIMENTAL; Interventions: Procedure: electronic tab | Intervention Type: PROCEDURE; Name: electronic tab; Assigned to Arm(s): Electronic tab | Intervention Type: DRUG; Name: Midazolam oral intake; Assigned to Arm(s): Hypnovel® (midazolam)
B: Arm Label: Standard technique; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard technique | Arm Label: Parent participation technique; Type: EXPERIMENTAL; Interventions: Behavioral: Parent participation technique | Intervention Type: BEHAVIORAL; Name: Standard technique; Assigned to Arm(s): Standard technique | Intervention Type: BEHAVIORAL; Name: Parent participation technique; Assigned to Arm(s): Parent participation technique
C: Arm Label: humanoid robot distration; Type: N/A; Interventions: N/A | Arm Label: control; Type: N/A; Interventions: N/A
D: Arm Label: Conventional syringe; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Camouflage syringe; Type: EXPERIMENTAL; Interventions: Procedure: Camouflage syringe | Intervention Type: PROCEDURE; Name: Camouflage syringe; Assigned to Arm(s): Camouflage syringe

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: SipSmarter: A Nutrition Literacy Approach to Reducing Sugary Beverages
Brief Summary: The primary aim of this pragmatic randomized-controlled trial was to determine the effectiveness of a scalable 6-month intervention aimed at decreasing SSB consumption (SIPsmartER) when compared to a matched contact physical activity promotion control group (MoveMore).


Options:
A: Arm Label: Sucrose; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Sucrose | Arm Label: Aspartame; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Aspartame | Intervention Type: DIETARY_SUPPLEMENT; Name: Sucrose; Assigned to Arm(s): Sucrose | Intervention Type: DIETARY_SUPPLEMENT; Name: Aspartame; Assigned to Arm(s): Aspartame
B: Arm Label: Intervention - PilAm Go4Health Program; Type: EXPERIMENTAL; Interventions: Behavioral: PilAm Go4Health Weight-loss Program | Arm Label: Active control - pedometer only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Active Control | Intervention Type: BEHAVIORAL; Name: PilAm Go4Health Weight-loss Program; Assigned to Arm(s): Intervention - PilAm Go4Health Program | Intervention Type: BEHAVIORAL; Name: Active Control; Assigned to Arm(s): Active control - pedometer only
C: Arm Label: SIPsmartER, behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: SipSmarter | Arm Label: Move More, behavioral intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: MoveMore | Intervention Type: BEHAVIORAL; Name: SipSmarter; Assigned to Arm(s): SIPsmartER, behavioral intervention | Intervention Type: BEHAVIORAL; Name: MoveMore; Assigned to Arm(s): Move More, behavioral intervention
D: Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Chef; Type: EXPERIMENTAL; Interventions: Other: Chef-enhanced meals | Arm Label: choice architecture; Type: EXPERIMENTAL; Interventions: Behavioral: choice architecture | Arm Label: Chef and choice architecture; Type: EXPERIMENTAL; Interventions: Behavioral: choice architecture, Other: Chef-enhanced meals | Intervention Type: BEHAVIORAL; Name: choice architecture; Assigned to Arm(s): Chef and choice architecture, choice architecture | Intervention Type: OTHER; Name: Chef-enhanced meals; Assigned to Arm(s): Chef, Chef and choice architecture

Answer: C